METHODS: Overall, 29.2% (38/130) of patients with MOGAD and 66.4% (83/125) of patients with AQP4-ab-positive NMOSD had ever experienced
myelitis. Compared with those with NMOSD, patients with MOGAD exhibited a lower frequency of
myelitis, either during the first episode (p < 0.0001) or throughout the disease duration (p < 0.0001). Compared with AQP4-ab-associated
myelitis, MOG-ab-associated
myelitis manifested a higher male-to-female ratio (p < 0.0001), younger age at disease onset (p = 0.0004), more prodromic
influenza-like symptoms (p = 0.030), more prodromic
fever (p = 0.0003), more bowel and bladder dysfunction (p = 0.011), less painful tonic
spasms (p < 0.0001), and lower Expanded Disability Status Scale scores
after treatment (p < 0.0001). On magnetic resonance imaging, lower spinal cord lesions (p = 0.023), short-segment lesions (p = 0.021), conus involvement (p = 0.0001), and H sign (p < 0.0001) were more common in MOG-ab-associated
myelitis. A scoring model with a cutoff value of 4 differentiated MOG-ab-associated
myelitis from AQP4-ab-associated
myelitis with a sensitivity of 87.9% and a specificity of 90.1%.
CONCLUSIONS: